Literature DB >> 21496569

Huntington's disease.

Karen E Anderson1.   

Abstract

Huntington's disease (HD) is an inherited disorder that causes neurological, cognitive, and psychiatric symptoms. Most patients with HD develop symptoms in all three of these domains, often concurrently. Problems in one area can impact and magnify symptoms in another domain. Limited treatment options exist for neurological and cognitive symptoms at this time, and no treatment exists to slow disease progression. In contrast, many behavioral symptoms respond to psychiatric medication. Thorough and aggressive treatment of psychiatric symptoms can positively impact both patient and caregiver quality of life, and may allow patients to remain longer in the home. There are currently numerous treatment trials not only for symptomatic therapy, but also for disease-modifying agents.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21496569     DOI: 10.1016/B978-0-444-52014-2.00002-1

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  6 in total

1.  The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study.

Authors:  Samuel Frank; Claudia Testa; Mary C Edmondson; Jody Goldstein; Elise Kayson; Blair R Leavitt; David Oakes; Christine O'Neill; Christina Vaughan; Jacquelyn Whaley; Nicholas Gross; Mark Forrest Gordon; Juha-Matti Savola
Journal:  CNS Drugs       Date:  2022-10-15       Impact factor: 6.497

2.  Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington's Disease-associated Chorea Initiated on Tetrabenazine.

Authors:  Victor W Sung; Ravi G Iyer; Sanjay K Gandhi; Victor Abler; Brian Davis; Debra E Irwin; Karen E Anderson
Journal:  J Health Econ Outcomes Res       Date:  2018-01-08

Review 3.  Risk-taking and pathological gambling behavior in Huntington's disease.

Authors:  Carla Kalkhoven; Cor Sennef; Ard Peeters; Ruud van den Bos
Journal:  Front Behav Neurosci       Date:  2014-04-02       Impact factor: 3.558

4.  An unusual presentation of Huntington's disease.

Authors:  Martin Schulze Westhoff; Alma Osmanovic; Catharina Meissner; Johannes Heck; Nima Mahmoudi; Corinna Hendrich; Georg Berding; Johanna Seifert; Stefan Bleich; Helge Frieling; Tillmann Krüger; Adrian Groh
Journal:  Clin Case Rep       Date:  2021-07-16

5.  Impact of Chorea on Self-care Activity, Employment, and Health-care Resource Use in Patients with Huntington's Disease.

Authors:  Daniel O Claassen; Jonathan DeCourcy; Jennifer Mellor; Charlotte Johnston; Ravi G Iyer
Journal:  J Health Econ Outcomes Res       Date:  2021-06-21

6.  Understanding How Chorea Affects Health-Related Quality of Life in Huntington Disease: An Online Survey of Patients and Caregivers in the United States.

Authors:  Eileen Mack Thorley; Ravi G Iyer; Paul Wicks; Chris Curran; Sanjay K Gandhi; Victor Abler; Karen E Anderson; Noelle E Carlozzi
Journal:  Patient       Date:  2018-10       Impact factor: 3.883

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.